<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-056127</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Corticosteroids and Osteoporosis</dc:title>
<dc:description xml:lang="en">Corticosteroids are the principal cause of secondary osteoporosis due to drug treatment. Doses of more than 5 mg daily and periods of treatment lasting more than 3 months increase the risk of osteoporosis and fragility fractures. It is therefore essential to be aware of measures to reduce the risk of osteoporosis in our patients</dc:description>
<dc:creator>Gantes, MA</dc:creator>
<dc:creator>García-Bustínduy, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La primera causa de osteoporosis secundaria a fármacos son los glucocorticoides. Dosis diarias superiores a 5 mg o dosificación durante más de 3 meses incrementan la osteoporosis y las fracturas por fragilidad. Resulta crucial conocer las medidas para minimizar la osteoporosis en nuestros enfermos</dc:description>
<dc:source>Actas Dermosifiliogr;98(8): 526-530, oct. 2007. tab</dc:source>
<dc:identifier>ibc-056127</dc:identifier>
<dc:title xml:lang="es">Corticoides y osteoporosis</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d10205^s22032</dc:subject>
<dc:subject>^d10205^s22036</dc:subject>
<dc:subject>^d4220^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d6082^s22020</dc:subject>
<dc:subject>^d50518^s22054</dc:subject>
<dc:type>article</dc:type>
<dc:date>200710</dc:date>
</metadata>
</record>
</ibecs-document>
